Last edition
News about "Sun Pharma Advanced Research Company "
SPARC Submits IND Application for SBO-154 to USFDA
Sun Pharma Advanced Research Company Ltd. (SPARC) has submitted an IND application to the US FDA for SBO-154, a novel antibody-drug conjugate (ADC) targeting advanced solid tumours.
Sun Pharma Advanced Research Company | 31/03/2025 | By Aishwarya | 363
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members